Published January 27, 2017
| Version v1
Journal article
Open
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis
Authors/Creators
- 1. Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;; Department of Molecular Medicine, University of Pavia, Pavia, Italy;
- 2. Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; and; Department of Internal Medicine, University of Pavia, Pavia, Italy
Description
Key Points
PDex can be a rescue regimen for patients with AL amyloidosis previously exposed to alkylators, proteasome inhibitors, and lenalidomide. Responses to PDex are frequent, rapid, and improve survival.
Files
fulltext.pdf
Files
(597.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:85cba9bbaa93c5a7060da0c13eceee73
|
597.6 kB | Preview Download |